Literature DB >> 10085058

beta1-chain integrins are not essential for intimin-mediated host cell attachment and enteropathogenic Escherichia coli-induced actin condensation.

H Liu1, L Magoun, J M Leong.   

Abstract

Intimin is a bacterial outer membrane protein required for intimate attachment of enterohemorrhagic and enteropathogenic Escherichia coli (EHEC and EPEC) to mammalian cells. beta1-chain integrins have been proposed as candidate receptors for intimin. We found that binding of mammalian cells to immobilized intimin was not detectable unless mammalian cells were preinfected with EPEC or EHEC. beta1-chain integrin antagonists or inactivation of the gene encoding the beta1-chain did not affect binding of preinfected mammalian cells to intimin or the actin condensation associated with the attachment of EPEC. The results indicate that beta1-chain integrins are not essential for intimin-mediated cell attachment or EPEC-mediated actin polymerization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085058      PMCID: PMC96568          DOI: 10.1128/IAI.67.4.2045-2049.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  Integrins: versatility, modulation, and signaling in cell adhesion.

Authors:  R O Hynes
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

2.  Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells.

Authors:  R R Isberg; J M Leong
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

3.  HeLa cell adherence, actin aggregation, and invasion by nonenteropathogenic Escherichia coli possessing the eae gene.

Authors:  J R Cantey; S L Moseley
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

4.  Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  J Yu; J B Kaper
Journal:  Mol Microbiol       Date:  1992-02       Impact factor: 3.501

5.  A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.

Authors:  A E Jerse; J Yu; B D Tall; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

6.  Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells.

Authors:  R R Isberg; D L Voorhis; S Falkow
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

7.  Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.

Authors:  M S Donnenberg; C O Tacket; S P James; G Losonsky; J P Nataro; S S Wasserman; J B Kaper; M M Levine
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  EspE, a novel secreted protein of attaching and effacing bacteria, is directly translocated into infected host cells, where it appears as a tyrosine-phosphorylated 90 kDa protein.

Authors:  C Deibel; S Krämer; T Chakraborty; F Ebel
Journal:  Mol Microbiol       Date:  1998-05       Impact factor: 3.501

9.  Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia.

Authors:  D B Schauer; S Falkow
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

10.  Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein.

Authors:  J M Leong; R S Fournier; R R Isberg
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more
  13 in total

1.  Interaction of enteropathogenic and Shiga toxin-producing Escherichia coli and porcine intestinal mucosa: role of intimin and Tir in adherence.

Authors:  Francis Girard; Isabelle Batisson; Gad M Frankel; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 2.  Adherence of diarrheagenic Escherichia coli strains to epithelial cells.

Authors:  Alfredo G Torres; Xin Zhou; James B Kaper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Synapses: sites of cell recognition, adhesion, and functional specification.

Authors:  Soichiro Yamada; W James Nelson
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

4.  EHEC Adhesins.

Authors:  Brian D McWilliams; Alfredo G Torres
Journal:  Microbiol Spectr       Date:  2014

5.  Actin pedestal formation by enterohemorrhagic Escherichia coli enhances bacterial host cell attachment and concomitant type III translocation.

Authors:  Scott E Battle; Michael J Brady; Sivapriya Kailasan Vanaja; John M Leong; Gail A Hecht
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

6.  Recruitment of cytoskeletal and signaling proteins to enteropathogenic and enterohemorrhagic Escherichia coli pedestals.

Authors:  D L Goosney; R DeVinney; B B Finlay
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin.

Authors:  L J Gansheroff; M R Wachtel; A D O'Brien
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

8.  The established intimin receptor Tir and the putative eucaryotic intimin receptors nucleolin and beta1 integrin localize at or near the site of enterohemorrhagic Escherichia coli O157:H7 adherence to enterocytes in vivo.

Authors:  James F Sinclair; Evelyn A Dean-Nystrom; Alison D O'Brien
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

Review 9.  Exploitation of host cells by enteropathogenic Escherichia coli.

Authors:  B A Vallance; B B Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

10.  Tissue tropism of enteropathogenic Escherichia coli strains belonging to the O55 serogroup.

Authors:  R J Fitzhenry; S Reece; L R Trabulsi; R Heuschkel; S Murch; M Thomson; G Frankel; A D Phillips
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.